Literature DB >> 21593414

Serotonin, cytokines, p11, and depression.

Solomon H Snyder1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21593414      PMCID： PMC3107307          DOI： 10.1073/pnas.1106103108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  9 in total

1.  Paroxetine for the prevention of depression induced by high-dose interferon alfa.

Authors:  D L Musselman; D H Lawson; J F Gumnick; A K Manatunga; S Penna; R S Goodkin; K Greiner; C B Nemeroff; A H Miller
Journal:  N Engl J Med       Date:  2001-03-29       Impact factor: 91.245

2.  Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans.

Authors:  Jennifer L Warner-Schmidt; Kimberly E Vanover; Emily Y Chen; John J Marshall; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

3.  Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

Authors:  Stephen Tyring; Alice Gottlieb; Kim Papp; Ken Gordon; Craig Leonardi; Andrea Wang; Deepa Lalla; Michael Woolley; Angelika Jahreis; Ralph Zitnik; David Cella; Ranga Krishnan
Journal:  Lancet       Date:  2006-01-07       Impact factor: 79.321

4.  Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study.

Authors:  Julien Mendlewicz; Philippe Kriwin; Pierre Oswald; Daniel Souery; Silvia Alboni; Nicoletta Brunello
Journal:  Int Clin Psychopharmacol       Date:  2006-07       Impact factor: 1.659

5.  Alterations in 5-HT1B receptor function by p11 in depression-like states.

Authors:  Per Svenningsson; Karima Chergui; Ilan Rachleff; Marc Flajolet; Xiaoqun Zhang; Malika El Yacoubi; Jean-Marie Vaugeois; George G Nomikos; Paul Greengard
Journal:  Science       Date:  2006-01-06       Impact factor: 47.728

6.  The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.

Authors:  N Müller; M J Schwarz; S Dehning; A Douhe; A Cerovecki; B Goldstein-Müller; I Spellmann; G Hetzel; K Maino; N Kleindienst; H-J Möller; V Arolt; M Riedel
Journal:  Mol Psychiatry       Date:  2006-02-21       Impact factor: 15.992

7.  Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation.

Authors:  Jennifer L Warner-Schmidt; Marc Flajolet; Abigail Maller; Emily Y Chen; Hongshi Qi; Per Svenningsson; Paul Greengard
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

Review 8.  Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.

Authors:  Andrew H Miller; Vladimir Maletic; Charles L Raison
Journal:  Biol Psychiatry       Date:  2009-01-15       Impact factor: 13.382

Review 9.  Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression.

Authors:  Michele L Pucak; Katherine A L Carroll; Douglas A Kerr; Adam I Kaplin
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986
  9 in total
  5 in total

Review 1.  Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability.

Authors:  Roberto Rodrigues; Robert B Petersen; George Perry
Journal:  Cell Mol Neurobiol       Date:  2014-06-14       Impact factor: 5.046

2.  Effect of Maternal ±Citalopram Exposure on P11 Expression and Neurogenesis in the Mouse Fetal Brain.

Authors:  Jennifer R King; Juan C Velasquez; Masaaki Torii; Alexandre Bonnin
Journal:  ACS Chem Neurosci       Date:  2017-01-13       Impact factor: 4.418

3.  Cytokine gene variations associated with trait and state anxiety in oncology patients and their family caregivers.

Authors:  Christine Miaskowski; Janine K Cataldo; Christina R Baggott; Claudia West; Laura B Dunn; Anand Dhruva; John D Merriman; Dale J Langford; Kord M Kober; Steven M Paul; Bruce A Cooper; Bradley E Aouizerat
Journal:  Support Care Cancer       Date:  2014-09-24       Impact factor: 3.603

4.  Effects of adult exposure to bisphenol a on genes involved in the physiopathology of rat prefrontal cortex.

Authors:  Beatriz Castro; Pilar Sánchez; Jesús M Torres; Esperanza Ortega
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

Review 5.  Serum S100B represents a new biomarker for mood disorders.

Authors:  Matthias L Schroeter; Julia Sacher; Johann Steiner; Peter Schoenknecht; Karsten Mueller
Journal:  Curr Drug Targets       Date:  2013-10       Impact factor: 3.465
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.